<?xml version="1.0" encoding="UTF-8"?>
<ref id="B106-molecules-26-00438">
 <label>106.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Shen</surname>
    <given-names>H.C.</given-names>
   </name>
   <name>
    <surname>Ding</surname>
    <given-names>F.-X.</given-names>
   </name>
   <name>
    <surname>Raghavan</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Deng</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Luell</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Forrest</surname>
    <given-names>M.J.</given-names>
   </name>
   <name>
    <surname>Carballo-Jane</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Wilsie</surname>
    <given-names>L.C.</given-names>
   </name>
   <name>
    <surname>Krsmanovic</surname>
    <given-names>M.L.</given-names>
   </name>
   <name>
    <surname>Taggart</surname>
    <given-names>A.K.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Discovery of a Biaryl Cyclohexene Carboxylic Acid (MK-6892): A Potent and Selective High Affinity Niacin Receptor Full Agonist with Reduced Flushing Profiles in Animals as a Preclinical Candidate</article-title>
  <source>J. Med. Chem.</source>
  <year>2010</year>
  <volume>53</volume>
  <fpage>2666</fpage>
  <lpage>2670</lpage>
  <pub-id pub-id-type="doi">10.1021/jm100022r</pub-id>
  <pub-id pub-id-type="pmid">20184326</pub-id>
 </element-citation>
</ref>
